Sunovion taps Empatica for Phase 4 drug trial and two other digital health projects targeting epilepsy

Posted on by timbatchelder

Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aption, a drug meant to reduce seizures in people with epilepsy.

Source: Sunovion taps Empatica for Phase 4 drug trial — and two other digital health projects targeting epilepsy | MobiHealthNews

Published by timbatchelder

Leave a Reply

Please log in using one of these methods to post your comment:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s